A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer

NCT01653561 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Apatinib

Sponsor

Fudan University

Collaborators

[object Object]